Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) was up 3.2% on Tuesday . The stock traded as high as $75.05 and last traded at $74.86. Approximately 459,048 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 2,756,136 shares. The stock had previously closed at $72.51.
Wall Street Analysts Forecast Growth
ALAB has been the topic of a number of recent research reports. Craig Hallum started coverage on Astera Labs in a research report on Monday, April 15th. They set a “buy” rating and a $90.00 target price on the stock. Roth Mkm initiated coverage on Astera Labs in a research report on Monday, April 15th. They set a “buy” rating and a $85.00 price objective on the stock. Stifel Nicolaus started coverage on Astera Labs in a research report on Monday, April 15th. They issued a “buy” rating and a $81.00 target price for the company. Evercore ISI initiated coverage on shares of Astera Labs in a research note on Tuesday, April 16th. They set an “outperform” rating and a $100.00 price target on the stock. Finally, Northland Securities started coverage on shares of Astera Labs in a research note on Monday, March 25th. They issued an “outperform” rating and a $85.00 price objective for the company. Eleven investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Astera Labs has an average rating of “Buy” and an average target price of $86.09.
View Our Latest Report on ALAB
Astera Labs Trading Up 4.3 %
Insider Buying and Selling at Astera Labs
In other news, Director Jack R. Lazar acquired 10,000 shares of the company’s stock in a transaction dated Friday, March 22nd. The stock was bought at an average price of $36.00 per share, with a total value of $360,000.00. Following the completion of the acquisition, the director now owns 165,000 shares in the company, valued at approximately $5,940,000. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Institutional Trading of Astera Labs
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Alpine Global Management LLC bought a new position in shares of Astera Labs during the first quarter worth $272,000. Central Pacific Bank Trust Division bought a new position in Astera Labs during the first quarter worth about $402,000. Sei Investments Co. bought a new stake in shares of Astera Labs in the first quarter worth about $952,000. Forge First Asset Management Inc. acquired a new stake in shares of Astera Labs during the first quarter worth about $1,143,000. Finally, Healthcare of Ontario Pension Plan Trust Fund bought a new position in shares of Astera Labs during the 1st quarter valued at about $1,484,000.
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Featured Articles
- Five stocks we like better than Astera Labs
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- First Quarter Wrap-Up Reveals Retail’s Shifting Sands
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Williams-Sonoma Stock Forecast to Hit $500? Here’s How
- How to Use the MarketBeat Dividend Calculator
- PDD Holdings Earnings Volatility Alerts Buyers
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.